Neuvantec Biopharma Ltd has been set up with the objective to be the pioneer in the healthcare and biopharmaceutical sector through the identification, development, and commercialisation of biopharmaceutical products meeting FDA/EMA/MHRA established quality standards.
From innovation to commitment, discover what sets Neuvantec Biopharma Ltd apart.
![]() |
Patient-Centric ApproachWe prioritize patient well-being, building confidence and trust among Mauritian and African patients through high-quality medicines |
![]() |
InnovationWe drive continuous biopharmaceutical innovation, crafting locally sourced solutions to address unique healthcare challenges in our target markets. |
![]() |
SustainabilityNeuvantec Biopharma Ltd is committed to a sustainable healthcare ecosystem,minimizing carbon footprints and creating value for shareholders, communities, and the environment. |
![]() |
Quality AssuranceCommitted to quality, Neuvantec Biopharma Ltd adheres to FDA/EMA/MHRA standards, ensuring safety and efficacy |
![]() |
Ethical PracticesWe build on ethical foundations, prioritizing transparency, integrity, and accountability in all interactions to instill trust in our operations. |
Neuvantec Biopharma Ltd is a Mauritian start-up incorporated in September 2023 as a private company, with the objective to identify, develop, and commercialise biopharmaceutical products for human use. The primary areas of focus of Neuvantec are therapeutics namely branded generics, Nutraceuticals and products incorporating food technologies, Dermo-cosmetics and Biomanufacturing. Neuvantec is in process of commercialisingRead more